Bo Lin

477 total citations
33 papers, 245 citations indexed

About

Bo Lin is a scholar working on Nephrology, Molecular Biology and Immunology. According to data from OpenAlex, Bo Lin has authored 33 papers receiving a total of 245 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Nephrology, 7 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Bo Lin's work include Renal Diseases and Glomerulopathies (9 papers), Parathyroid Disorders and Treatments (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Bo Lin is often cited by papers focused on Renal Diseases and Glomerulopathies (9 papers), Parathyroid Disorders and Treatments (3 papers) and Chronic Kidney Disease and Diabetes (3 papers). Bo Lin collaborates with scholars based in China, United States and Australia. Bo Lin's co-authors include Qiang He, Yiwen Li, Juan Jin, Wang Jun-wei, Ying‐Yu Ma, Juan Jin, Jianguang Gong, Xiaogang Shen, Chengzhong Peng and Yingfan Hu and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Infectious Diseases.

In The Last Decade

Bo Lin

30 papers receiving 238 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bo Lin China	11	92	78	67	32	31	33	245
Shin-ichiro Okizaki Japan	8	72 0.8×	76 1.0×	53 0.8×	37 1.2×	20 0.6×	10	347
Amanda P. Waller United States	12	97 1.1×	124 1.6×	41 0.6×	23 0.7×	25 0.8×	40	465
Puxun Tian China	12	69 0.8×	120 1.5×	89 1.3×	22 0.7×	17 0.5×	36	346
Charbel C. Khoury United States	8	133 1.4×	106 1.4×	41 0.6×	17 0.5×	15 0.5×	14	313
Chi‐Pin Lee Taiwan	14	64 0.7×	139 1.8×	46 0.7×	39 1.2×	35 1.1×	22	345
Sameen Fatima Germany	9	92 1.0×	103 1.3×	37 0.6×	38 1.2×	25 0.8×	16	326
Shaodong Luan China	8	48 0.5×	125 1.6×	71 1.1×	28 0.9×	25 0.8×	35	281
Yu‐Cheng Lai Taiwan	11	23 0.3×	56 0.7×	46 0.7×	35 1.1×	60 1.9×	31	248
Yoko Mitsuda Japan	10	40 0.4×	91 1.2×	98 1.5×	69 2.2×	28 0.9×	15	358

Countries citing papers authored by Bo Lin

Since Specialization

Citations

This map shows the geographic impact of Bo Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Lin more than expected).

Fields of papers citing papers by Bo Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Lin. The network helps show where Bo Lin may publish in the future.

Co-authorship network of co-authors of Bo Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Lin. A scholar is included among the top collaborators of Bo Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Lin. Bo Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jiang, Feng, et al.. (2025). Knowledge, attitudes, and practice toward atherosclerosis and ultrasound screening in adults in Shanghai. Scientific Reports. 15(1). 15480–15480.

Liu, Xiaobin, Jing Xue, Ting Li, et al.. (2024). Quantitative detection and prognostic value of antibodies against M-type phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy. PLoS ONE. 19(2). e0298269–e0298269. 1 indexed citations

Lin, Bo, Peng Yu, Di Zhang, et al.. (2024). Scutellaria baicalensis water decoction ameliorates lower respiratory tract infection by modulating respiratory microbiota. Phytomedicine. 129. 155706–155706. 9 indexed citations

Jin, Juan, Fen Chen, Wenfang He, et al.. (2023). YAP-Activated SATB2 Is a Coactivator of NRF2 That Amplifies Antioxidative Capacity and Promotes Tumor Progression in Renal Cell Carcinoma. Cancer Research. 83(5). 786–803. 14 indexed citations

Liu, Haojie, Danna Zheng, Wenfang He, et al.. (2023). Misdiagnosis of chronic kidney disease and parathyroid hormone testing during the past 16 years. Scientific Reports. 13(1). 15838–15838. 1 indexed citations

Yu, Peng, Bo Lin, Di Zhang, et al.. (2023). Noninvasive Intratracheal Lipopolysaccharide Instillation in Mice. Journal of Visualized Experiments. 4 indexed citations

Chen, Lingli, Bo Lin, Xue Yang, et al.. (2022). Establishment of Galectin-3 Time-resolved Fluoroimmunoassay and its Application in Idiopathic Membranous Nephropathy. Journal of Fluorescence. 32(2). 629–636. 2 indexed citations

Zheng, Danna, Juan Wu, Yueming Liu, et al.. (2022). Efficacy and safety of radiofrequency ablation versus parathyroidectomy for secondary hyperparathyroidism in dialysis patients: a single-center retrospective study. Scientific Reports. 12(1). 10289–10289. 12 indexed citations

Lin, Bo, Ying‐Yu Ma, & Wang Jun-wei. (2022). Nano-Technological Approaches for Targeting Kidney Diseases With Focus on Diabetic Nephropathy: Recent Progress, and Future Perspectives. Frontiers in Bioengineering and Biotechnology. 10. 870049–870049. 20 indexed citations

10.

Zhu, Xiaodong, Xiaogang Shen, Bo Lin, et al.. (2022). Liuwei Dihuang Pills Inhibit Podocyte Injury and Alleviate IgA Nephropathy by Directly Altering Mesangial Cell-Derived Exosome Function and Secretion. Frontiers in Pharmacology. 13. 889008–889008. 12 indexed citations

11.

Lin, Bo, et al.. (2020). Laparoscopic preperitoneal tunneling technique using a novel device for peritoneal dialysis catheter placement. Clinical and Experimental Nephrology. 24(11). 1044–1049.

12.

Peng, Chengzhong, et al.. (2020). Efficacy of Ultrasound-guided Radiofrequency Ablation of Parathyroid Hyperplasia: Single Session vs. Two-Session for Effect on Hypocalcemia. Scientific Reports. 10(1). 6206–6206. 28 indexed citations

13.

Lü, Qing, Tiantian Lei, Yilan Wang, et al.. (2019). Development and validation of a model to determine risk of refractory benign esophageal strictures. World Journal of Clinical Cases. 7(13). 1623–1633. 7 indexed citations

14.

Lin, Bo, et al.. (2019). Development of polypyrrole/collagen/nano-strontium substituted bioactive glass composite for boost sciatic nerve rejuvenation in vivo. Artificial Cells Nanomedicine and Biotechnology. 47(1). 3423–3430. 10 indexed citations

15.

Jin, Juan, Jianguang Gong, Bo Lin, Yiwen Li, & Qiang He. (2017). FcγRIIb expression on B cells is associated with treatment efficacy for acute rejection after kidney transplantation. Molecular Immunology. 85. 283–292. 6 indexed citations

16.

Jin, Juan, et al.. (2017). Association of podocyte autophagosome numbers with idiopathic membranous nephropathy and secondary membranous nephropathy. International Urology and Nephrology. 49(6). 1025–1031. 13 indexed citations

17.

Jin, Juan, et al.. (2016). How many podocyte autophagosomes are there in immunoglobulin A nephropathy and idiopathic membranous nephropathy?. International Urology and Nephrology. 48(12). 2109–2114. 13 indexed citations

18.

Wang, Yan & Bo Lin. (2013). In silico investigations of potential anabolic treatments in multiple myeloma-induced bone disease. Bone. 55(1). 132–149. 2 indexed citations

19.

Wang, Yan & Bo Lin. (2012). In Silico Investigations of the Anti-Catabolic Effects of Pamidronate and Denosumab on Multiple Myeloma-Induced Bone Disease. PLoS ONE. 7(9). e44868–e44868. 4 indexed citations

20.

Lin, Bo, et al.. (1998). Pacemaker Lead Infection and Vertebral Osteomyelitis Presumed Due to Cardiobacterium hominis. Clinical Infectious Diseases. 27(4). 890–891. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact